{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12221591", "DateCompleted": {"Year": "2002", "Month": "11", "Day": "19"}, "DateRevised": {"Year": "2014", "Month": "11", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0032-0943", "JournalIssue": {"Volume": "68", "Issue": "8", "PubDate": {"Year": "2002", "Month": "Aug"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Muscarinic agonist properties involved in the hypotensive and vasorelaxant responses of rotundifolone in rats.", "Pagination": {"StartPage": "700", "EndPage": "704", "MedlinePgn": "700-4"}, "Abstract": {"AbstractText": ["The acute cardiovascular effects of rotundifolone (ROT), the major constituent (63.5 %) of the essential oil of Mentha x villosa (OEMV), were tested in rats by using a combined (in vivo and in vitro) approach. ROT (1, 5, 10, 20 and 30 mg kg(-1) i. v.) induced a significant and dose-dependent hypotension and bradycardia in non-anaesthetized normotensive rats. The hypotensive effect was significantly attenuated by pre-treatment of the rats with atropine (2 mg kg(-1) i. v.) or L-NAME (20 mg kg(-1) i. v.). Furthermore, the bradycardic effect was abolished by atropine. In isolated rat atrial preparations, ROT (10, 100, 300 and 500 microg ml(-1)) produced concentration-related negative inotropic and chronotropic effects. In isolated intact aortic rings, increasing concentractions of ROT (0.3, 1, 10, 100, 300 and 500 microg ml(-1)) were able to antagonize the contractile effect of phenylephrine (1 microM) (IC50 = 184 +/- 6 microg ml(-1)). The smooth muscle-relaxant activity of ROT was inhibited by either removal of vascular endothelium, atropine (1 microM), L-NAME (100 and 300 microM) or indomethacin (10 microM) (IC50 values = 235 +/- 7, 247 +/- 8, 387 +/- 21, 723 +/- 75 and 573 +/- 38 microg ml(-1), respectively). These results suggest that rotundifolone markedly lowers arterial pressure and heart rate in non-anaesthetized animals. The hypotensive action of rotundifolone can be a consequence of a decrease in heart rate and peripheral vascular resistance, probably due to a non-selective muscarinic receptor stimulation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laborat\u00f3rio de Tecnologia Farmac\u00eautica, Universidade Federal da Para\u00edba, Jo\u00e3o Pessoa, PB, Brazil."}], "Identifier": [], "LastName": "Guedes", "ForeName": "D N", "Initials": "DN"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Silva", "ForeName": "D F", "Initials": "DF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Barbosa-Filho", "ForeName": "J M", "Initials": "JM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Medeiros", "ForeName": "I A", "Initials": "IA"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Monoterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Muscarinic Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasoconstrictor Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "6FR5IOD112", "NameOfSubstance": "rotundifolone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart Atria"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Hypotension"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Mentha"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Monoterpenes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Muscarinic Agonists"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Contraction"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasoconstrictor Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vasodilation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "9", "Day": "11", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "11", "Day": "26", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "9", "Day": "11", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12221591", "10.1055/s-2002-33795"]}}], "PubmedBookArticle": []}